Postpartum hemorrhage and low fibrinogen levels: The past, present and future

International Journal of Obstetric Anesthesia

Volumn 22, Issue 2, 2013, Pages 87-91

  Butwick, A J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBRINOLYTIC AGENT; ESTROGEN; FIBRINOGEN; FIBRINOGEN CONCENTRATE; FIBRINOGEN RECEPTOR; FRESH FROZEN PLASMA; HEMOGLOBIN; PLACEBO; TRANEXAMIC ACID;

CRYOPRECIPITATE; DISEASE SEVERITY; DRUG MEGADOSE; ERYTHROCYTE COUNT; ERYTHROCYTE TRANSFUSION; GESTATIONAL AGE; HEALTH CARE QUALITY; HEMOSTASIS; HUMAN; HYPOFIBRINOGENEMIA; LOADING DRUG DOSE; MATERNAL MORBIDITY; MATERNAL MORTALITY; OUTCOME ASSESSMENT; POINT OF CARE TESTING; POSTPARTUM HEMORRHAGE; PREGNANT WOMAN; REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOELASTOGRAPH; THROMBOELASTOGRAPHY; TRANSFUSION;

EID: 84875739848     PISSN: 0959289X     EISSN: 15323374     Source Type: Journal    
DOI: 10.1016/j.ijoa.2013.01.002     Document Type: Editorial

References (44)

1. Centre for Maternal and Child Enquiries (CEMACE). Saving Mothers' Lives: Reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 2011;118 Suppl. 1:1-203.
2. C.J. Berg, W.M. Callaghan, C. Syverson, and Z. Henderson Pregnancy-related mortality in the United States, 1998 to 2005 Obstet Gynecol 116 2010 1302 1309
3. M. Knight, W.M. Callaghan, and C. Berg Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group BMC Pregnancy Childbirth 9 2009 55
4. W.M. Callaghan, A.A. Creanga, and E.V. Kuklina Severe maternal morbidity among delivery and postpartum hospitalizations in the United States Obstet Gynecol 120 2012 1029 1036
5. Hemorrhage Taskforce CMQCCC. OB Hemorrhage Toolkit 2009. URL = http://www.cmqcc.org/ob-hemorrhage [Accessed March 2012].
6. D. Bingham, A. Lyndon, D. Lagrew, and E.K. Main A state-wide obstetric hemorrhage quality improvement initiative MCN Am J Matern Child Nurs 36 2011 297 304
7. L.E. Shields, K. Smalarz, L. Reffigee, S. Mugg, T.J. Burdumy, and M. Propst Comprehensive maternal hemorrhage protocols improve patient safety and reduce utilization of blood products Am J Obstet Gynecol 205 2011 e361 e368
8. J.W. Weisel, C. Nagaswami, G. Vilaire, and J.S. Bennett Examination of the platelet membrane glycoprotein IIb-IIIa complex and its interaction with fibrinogen and other ligands by electron microscopy J Biol Chem 267 1992 16637 16643
9. M.W. Mosesson Fibrinogen and fibrin structure and functions J Thromb Haemost 3 2005 1894 1904 (Pubitemid 41716577)
10. C. Huissoud, N. Carrabin, and M. Benchaib Coagulation assessment by rotation thrombelastometry in normal pregnancy Thromb Haemost 101 2009 755 761
11. G. Adler, T. Duchinski, A. Jasinska, and U. Piotrowska Fibrinogen fractions in the third trimester of pregnancy and in puerperium Thromb Res 97 2000 405 410 (Pubitemid 30125706)
12. E.H. Uchikova, and I.I. Ledjev Changes in haemostasis during normal pregnancy Eur J Obstet Gynecol Reprod Biol 119 2005 185 188 (Pubitemid 40460379)
13. F. Cerneca, G. Ricci, R. Simeone, M. Malisano, S. Alberico, and S. Guaschino Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis Eur J Obstet Gynecol Reprod Biol 73 1997 31 36 (Pubitemid 27224457)
14. R.D. Oliver, B.B. Patterson, and J.L. Puls Thrombin clottable determination of plasma fibrinogen in pregnancy Obstet Gynecol 47 1976 299 303
15. G.T. Manten, A. Franx, and J.M. Sikkema Fibrinogen and high molecular weight fibrinogen during and after normal pregnancy Thromb Res 114 2004 19 23 (Pubitemid 38942971)
16. J.W. Choi, and S.H. Pai Tissue plasminogen activator levels change with plasma fibrinogen concentrations during pregnancy Ann Hematol 81 2002 611 615 (Pubitemid 36075513)
17. L. Hahn, and K. Korsan-Bengtsen The coagulation system during caesarean section. Coagulation, fibrinolysis and hormonal levels in peripheral and uterine venous blood during caesarean section Acta Obstet Gynecol Scand 54 1975 49 55
18. J. Bonnar, C.R. Prentice, G.P. McNicol, and A.S. Douglas Haemostatic mechanism in the uterine circulation during placental separation BMJ 2 1970 564 567
19. A. Butwick, V. Ting, L.A. Ralls, S. Harter, and E. Riley The association between thromboelastographic parameters and total estimated blood loss in patients undergoing elective cesarean delivery Anesth Analg 112 2011 1041 1047
20. B. Charbit, L. Mandelbrot, and E. Samain The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage J Thromb Haemost 5 2007 266 273 (Pubitemid 46139450)
21. M. Cortet, C. Deneux-Tharaux, and C. Dupont Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial Br J Anaesth 108 2012 984 989
22. L. de Lloyd, R. Bovington, and A. Kaye Standard haemostatic tests following major obstetric haemorrhage Int J Obstet Anesth 20 2011 135 141
23. E. Gayat, M. Resche-Rigon, and O. Morel Predictive factors of advanced interventional procedures in a multicentre severe postpartum haemorrhage study Intensive Care Med 37 2011 1816 1825
24. C. Huissoud, N. Carrabin, and F. Audibert Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombelastometry BJOG 116 2009 1097 1102
25. C. Solomon, R.E. Collis, and P.W. Collins Haemostatic monitoring during postpartum haemorrhage and implications for management Br J Anaesth 109 2012 851 863
26. K. Benirschke, and G.J. Burton Involution of the implantation site: retained placenta B. Benirschke, G.J. Burton, R.N. Baergen, Pathology of the human placenta 6th ed. 2012 Springer Berlin 241 248
27. H. Ludwig Surface structure of the human term placenta and of the uterine wall post partum in the screen scan electron microscope Am J Obstet Gynecol 111 1971 328 344
28. J.H. Levy, F. Szlam, K.A. Tanaka, and R.M. Sniecienski Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding Anesth Analg 114 2012 261 274
29. D. Bolliger, F. Szlam, R.J. Molinaro, N. Rahe-Meyer, J.H. Levy, and K.A. Tanaka Finding the optimal concentration range for fibrinogen replacement after severe haemodilution: an in vitro model Br J Anaesth 102 2009 793 799
30. C. Rourke, N. Curry, and S. Khan Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes J Thromb Haemost 10 2012 1342 1351
31. C. Fenger-Eriksen, J. Ingerslev, and B. Sorensen Fibrinogen concentrate - a potential universal hemostatic agent Expert Opin Biol Ther 9 2009 1325 1333
32. J.H. Levy, F. Szlam, K.A. Tanaka, and R.M. Sniecienski Fibrinogen and hemostasis: a primary hemostatic target for the management of acquired bleeding Anesth Analg 114 2012 261 274
33. M. Franchini, and G. Lippi Fibrinogen replacement therapy: a critical review of the literature Blood Transfus 10 2012 23 27
34. Kikuchi M, Itakura A, Miki A, Nishibayashi M, Ikebuchi K, Ishihara O. Fibrinogen concentrate substitution therapy for obstetric hemorrhage complicated by coagulopathy. J Obstet Gynaecol Res 2012 [epub ahead of print].
35. S.F. Bell, R. Rayment, P.W. Collins, and R.E. Collis The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage Int J Obstet Anesth 19 2010 218 223
36. N.J. Glover, R.E. Collis, and P. Collins Fibrinogen concentrate use during major obstetric haemorrhage Anaesthesia 65 2010 1229 1230
37. C. Fenger-Eriksen, G.W. Moore, S. Rangarajan, J. Ingerslev, and B. Sorensen Fibrinogen estimates are influenced by methods of measurement and hemodilution with colloid plasma expanders Transfusion 50 2010 2571 2576
38. S. Ahmed, C. Harrity, and S. Johnson The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage-an observational study Transfus Med 22 2012 344 349
39. P. Peitsidis, and R.A. Kadir Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum Expert Opin Pharmacother 12 2011 503 516
40. A.S. Ducloy-Bouthors, B. Jude, and A. Duhamel High-dose tranexamic acid reduces blood loss in postpartum haemorrhage Crit Care 15 2011 R117
41. N.F. Collins, M. Bloor, and N.J. McDonnell Hyperfibrinolysis diagnosed by rotational thromboelastometry in a case of suspected amniotic fluid embolism Int J Obstet Gynecol 22 2012 71 76
42. D.R. Spahn, and M.T. Ganter Towards early individual goal-directed coagulation management in trauma patients Br J Anaesth 105 2010 103 105
43. A.J. Wikkelsoe, A. Afshari, and J. Stensballe The FIB-PPH trial: fibrinogen concentrate as initial treatment for postpartum haemorrhage: study protocol for a randomised controlled trial Trials 13 2012 110
44. H. Shakur, D. Elbourne, and M. Gulmezoglu The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial Trials 11 2010 40